Aethlon Medical (AEMD) Shareholder's Equity Growth (3y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Aethlon Medical | 1.14 Mn | -5.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -27.03% |
| Sep 30, 2025 | -33.87% |
| Jun 30, 2025 | -38.78% |
| Mar 31, 2025 | -32.94% |
| Dec 31, 2024 | -40.48% |
| Sep 30, 2024 | -35.94% |
| Jun 30, 2024 | -29.38% |
| Mar 31, 2024 | -14.71% |
| Dec 31, 2023 | -12.69% |
| Sep 30, 2023 | -8.72% |
| Jun 30, 2023 | -4.79% |
| Mar 31, 2023 | 17.54% |
| Dec 31, 2022 | 65.61% |
| Sep 30, 2022 | 886.87% |
| Jun 30, 2022 | 144.71% |
| Mar 31, 2022 | 94.79% |
| Dec 31, 2021 | 86.49% |
| Sep 30, 2021 | 78.72% |
| Jun 30, 2021 | 69.15% |
| Mar 31, 2021 | 15.49% |
| Dec 31, 2020 | 35.43% |
| Sep 30, 2020 | 786.68% |
| Jun 30, 2020 | 169.39% |
| Mar 31, 2020 | 149.77% |
| Dec 31, 2019 | 270.95% |
| Sep 30, 2019 | 29.17% |
| Jun 30, 2019 | 32.94% |
| Mar 31, 2019 | 15.24% |
| Dec 31, 2018 | 5.38% |
| Sep 30, 2018 | 0.93% |
| Jun 30, 2018 | 0.23% |
| Mar 31, 2018 | 110.00% |
| Dec 31, 2017 | 52.63% |
| Sep 30, 2017 | 26.12% |
| Jun 30, 2017 | 38.34% |
| Mar 31, 2017 | 26.84% |
| Dec 31, 2016 | 26.14% |
| Sep 30, 2016 | 77.39% |
| Jun 30, 2016 | 27.02% |
| Mar 31, 2016 | 29.35% |
| Dec 31, 2015 | 33.33% |
| Sep 30, 2015 | 35.00% |
| Jun 30, 2015 | 37.59% |
| Mar 31, 2015 | 27.45% |
| Dec 31, 2014 | 30.29% |
| Sep 30, 2014 | 19.64% |
| Jun 30, 2014 | 18.05% |
| Mar 31, 2014 | -35.08% |